We hope that you'll join us for STAT@ASH: From Sickle Cell to Cancer.
Hi Aamir, Attending this year's ASH meeting? We'd like to personally invite you to join us this Saturday, December 7 in San Diego for STAT@ASH: From Sickle Cell to Cancer, an exclusive STAT News event exploring the future of hematology. This can't-miss gathering will feature an executive panel with leaders from GSK, Johnson & Johnson, AstraZeneca, and Regeneron, discussing how cutting-edge technologies like bispecific antibodies and precision medicines are transforming the treatment of hematological cancers. STAT's Adam Feuerstein will also lead a session on key developments and challenges in sickle cell treatment, featuring a group of experts who will provide valuable insights into the field's future. Beyond the sessions, this is a fantastic opportunity to connect with other leaders in hematology in an engaging, collaborative setting. Use this link to RSVP. We hope to see you there! ~The STAT Events Team |
|
No comments